Literature DB >> 3530297

The management of hypertension.

B N Prichard, C W Owens.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530297      PMCID: PMC1400731          DOI: 10.1111/j.1365-2125.1986.tb02862.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  171 in total

1.  Antihypertensive and beta-adrenoceptor antagonist action of timolol.

Authors:  G Simon; W Kiowski; S Julius
Journal:  Clin Pharmacol Ther       Date:  1978-02       Impact factor: 6.875

2.  Beta-blockers and asthma.

Authors:  P B Decalmer; S S Chatterjee; J M Cruickshank; M K Benson; G M Sterling
Journal:  Br Heart J       Date:  1978-02

3.  Slow channel inhibitors verapamil and nifedipine in the management of hypertension.

Authors:  B A Gould; R S Hornung; S Mann; V Balasubramanian; E B Raftery
Journal:  J Cardiovasc Pharmacol       Date:  1982       Impact factor: 3.105

Review 4.  Beta-adrenergic receptor blocking drugs in angina pectoris.

Authors:  B N Prichard
Journal:  Drugs       Date:  1974       Impact factor: 9.546

5.  Nifedipine, a new antihypertensive with rapid action.

Authors:  M Guazzi; M T Olivari; A Polese; C Fiorentini; F Magrini; P Moruzzi
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

6.  Treatment of hypertension with nifedipine, a calcium antagonistic agent.

Authors:  M T Olivari; C Bartorelli; A Polese; C Fiorentini; P Moruzzi; M D Guazzi
Journal:  Circulation       Date:  1979-05       Impact factor: 29.690

7.  Prazosin first dose phenomenon during combined treatment with a beta-adrenoceptor blocker in hypertensive patients.

Authors:  P Seideman; A Grahnén; K Haglund; B Lindström; C Von Bahr
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

8.  Rate of onset of hypotensive effect of oral labetalol.

Authors:  M J Serlin; M C Orme; M Maciver; G J Green; C M Macnee; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

9.  Effect of pindolol on serum lipids and lipid metabolizing enzymes.

Authors:  A Lehtonen; E Hietanen; J Marniemi; P Peltonen; J Niskanen
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

10.  Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol.

Authors:  J H Jürgensen; J Frederiksen; D A Hansen; O Pedersen-Bjergaard
Journal:  Br Heart J       Date:  1981-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.